PL376916A1 - Pochodne pirymido [4,5-d] pirymidyny o działaniu przeciwrakowym - Google Patents
Pochodne pirymido [4,5-d] pirymidyny o działaniu przeciwrakowymInfo
- Publication number
- PL376916A1 PL376916A1 PL376916A PL37691603A PL376916A1 PL 376916 A1 PL376916 A1 PL 376916A1 PL 376916 A PL376916 A PL 376916A PL 37691603 A PL37691603 A PL 37691603A PL 376916 A1 PL376916 A1 PL 376916A1
- Authority
- PL
- Poland
- Prior art keywords
- pyrimido
- pyrimidine derivatives
- anticancer activity
- anticancer
- pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42367002P | 2002-11-04 | 2002-11-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL376916A1 true PL376916A1 (pl) | 2006-01-09 |
Family
ID=32312700
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL376916A PL376916A1 (pl) | 2002-11-04 | 2003-10-27 | Pochodne pirymido [4,5-d] pirymidyny o działaniu przeciwrakowym |
| PL376924A PL376924A1 (pl) | 2002-11-04 | 2003-10-27 | Związki pirymidynowe o działaniu przeciwproliferacyjnym (II) |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL376924A PL376924A1 (pl) | 2002-11-04 | 2003-10-27 | Związki pirymidynowe o działaniu przeciwproliferacyjnym (II) |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7129351B2 (pl) |
| EP (2) | EP1560829B1 (pl) |
| JP (2) | JP2006513999A (pl) |
| KR (4) | KR100774231B1 (pl) |
| CN (2) | CN1711266A (pl) |
| AR (2) | AR041739A1 (pl) |
| AT (2) | ATE384725T1 (pl) |
| AU (1) | AU2003276190A1 (pl) |
| BR (2) | BR0316001A (pl) |
| CA (2) | CA2502180A1 (pl) |
| DE (2) | DE60319260T2 (pl) |
| ES (2) | ES2300609T3 (pl) |
| MX (2) | MXPA05004757A (pl) |
| PL (2) | PL376916A1 (pl) |
| RU (2) | RU2326882C2 (pl) |
| WO (2) | WO2004041821A1 (pl) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003903501A0 (en) * | 2003-07-07 | 2003-07-24 | Commonwealth Scientific And Industrial Research Organisation | A method of forming a reflective authentication device |
| WO2005011597A2 (en) * | 2003-07-29 | 2005-02-10 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| FR2873127B1 (fr) | 2004-07-13 | 2008-08-29 | Omya Development Ag | Procede de fabrication de particules pigmentaires autoliantes, seches ou en suspension ou dispersion aqueuses, contenant des matieres inorganiques et des liants |
| MX2007002096A (es) | 2004-08-31 | 2007-03-29 | Hoffmann La Roche | Derivados de amida de 3-fenil-dihidropirimido[4,5-d] pirimidinonas, su fabricacion y su uso como agentes farmaceuticos. |
| CA2576924A1 (en) | 2004-08-31 | 2006-03-09 | F. Hoffmann-La Roche Ag | Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents |
| PT1951684T (pt) * | 2005-11-01 | 2016-10-13 | Targegen Inc | Inibidores de cinases de tipo biaril-meta-pirimidina |
| JP2009525292A (ja) | 2006-01-31 | 2009-07-09 | エフ．ホフマン−ラ ロシュ アーゲー | ７ｈ−ピリド［３，４−ｄ］ピリミジン−８−オン、それらの製造及びプロテインキナーゼ阻害剤としての使用 |
| CA2646369A1 (en) * | 2006-03-29 | 2007-11-08 | North Carolina State University | Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives |
| AU2007254491A1 (en) * | 2006-05-15 | 2007-11-29 | Irm Llc | Compositions and methods for FGF receptor kinases inhibitors |
| US7897762B2 (en) * | 2006-09-14 | 2011-03-01 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of proliferative diseases |
| JP2011529920A (ja) * | 2008-07-31 | 2011-12-15 | ジェネンテック， インコーポレイテッド | ピリミジン化合物、組成物及び使用方法 |
| MX2011002793A (es) | 2008-09-25 | 2011-04-05 | Hoffmann La Roche | Derivados de 3-amino-indazol o de 3-amino-4,5,6,7-tetrahidro-indaz ol. |
| CA2745970A1 (en) | 2008-12-12 | 2010-06-17 | Msd K.K. | Dihydropyrimidopyrimidine derivative |
| WO2010067888A1 (en) * | 2008-12-12 | 2010-06-17 | Banyu Pharmaceutical Co.,Ltd. | Dihydropyrimidopyrimidine derivatives |
| HUP0800768A2 (en) | 2008-12-18 | 2012-08-28 | Bioblocks Magyarorszag Gyogyszerkemiai Es Fejlesztoe Kft | 1,3-heterocycles condensed with monoterpene skeleton, their use and pharmaceutical compositions comprising such compounds |
| WO2010099139A2 (en) | 2009-02-25 | 2010-09-02 | Osi Pharmaceuticals, Inc. | Combination anti-cancer therapy |
| EP2401613A2 (en) | 2009-02-27 | 2012-01-04 | OSI Pharmaceuticals, LLC | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
| WO2010099138A2 (en) | 2009-02-27 | 2010-09-02 | Osi Pharmaceuticals, Inc. | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
| WO2010099363A1 (en) | 2009-02-27 | 2010-09-02 | Osi Pharmaceuticals, Inc. | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
| US20100318651A1 (en) * | 2009-06-10 | 2010-12-16 | Everis, Inc. | Network Communication System With Monitoring |
| WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
| WO2012149014A1 (en) | 2011-04-25 | 2012-11-01 | OSI Pharmaceuticals, LLC | Use of emt gene signatures in cancer drug discovery, diagnostics, and treatment |
| GB201204384D0 (en) | 2012-03-13 | 2012-04-25 | Univ Dundee | Anti-flammatory agents |
| WO2013152252A1 (en) | 2012-04-06 | 2013-10-10 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
| PT3176170T (pt) | 2012-06-13 | 2019-02-05 | Incyte Holdings Corp | Compostos tricíclicos substituídos como inibidores de fgfr |
| SG10201805807PA (en) | 2012-06-26 | 2018-08-30 | Del Mar Pharmaceuticals | Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof |
| WO2014026125A1 (en) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Pyrazine derivatives as fgfr inhibitors |
| US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
| AU2014228746B2 (en) | 2013-03-15 | 2018-08-30 | Celgene Car Llc | Heteroaryl compounds and uses thereof |
| KR102350704B1 (ko) | 2013-03-15 | 2022-01-13 | 셀젠 카르 엘엘씨 | 헤테로아릴 화합물 및 이의 용도 |
| AR095464A1 (es) | 2013-03-15 | 2015-10-21 | Celgene Avilomics Res Inc | Compuestos de heteroarilo y usos de los mismos |
| KR102469849B1 (ko) | 2013-04-19 | 2022-11-23 | 인사이트 홀딩스 코포레이션 | Fgfr 저해제로서 이환식 헤테로사이클 |
| AU2014287209B2 (en) | 2013-07-09 | 2019-01-24 | Dana-Farber Cancer Institute, Inc. | Kinase inhibitors for the treatment of disease |
| US10287268B2 (en) | 2014-07-21 | 2019-05-14 | Dana-Farber Cancer Institute, Inc. | Imidazolyl kinase inhibitors and uses thereof |
| DK3172213T3 (da) | 2014-07-21 | 2021-12-13 | Dana Farber Cancer Inst Inc | Makrocykliske kinasehæmmere og anvendelser deraf |
| EP3536323A1 (en) | 2014-08-08 | 2019-09-11 | Dana Farber Cancer Institute, Inc. | Uses of salt-inducible kinase (sik) inhibitors |
| US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| SG11201706287PA (en) | 2015-02-20 | 2017-09-28 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors |
| US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| CN110225914A (zh) * | 2016-07-05 | 2019-09-10 | 布罗德研究所股份有限公司 | 双环脲激酶抑制剂及其用途 |
| US11241435B2 (en) | 2016-09-16 | 2022-02-08 | The General Hospital Corporation | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis |
| CN111163771B (zh) | 2017-02-28 | 2023-07-14 | 通用医疗公司 | 嘧啶并嘧啶酮类作为sik抑制剂的用途 |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| PE20210920A1 (es) | 2018-05-04 | 2021-05-19 | Incyte Corp | Formas solidas de un inhibidor de fgfr y procesos para prepararlas |
| CN112566912A (zh) | 2018-05-04 | 2021-03-26 | 因赛特公司 | Fgfr抑制剂的盐 |
| AU2019414446A1 (en) * | 2018-12-27 | 2021-07-15 | Les Laboratoires Servier Sas | Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer |
| WO2020185532A1 (en) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Methods of treating cancer with an fgfr inhibitor |
| US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| US12122767B2 (en) | 2019-10-01 | 2024-10-22 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| TW202128685A (zh) | 2019-10-14 | 2021-08-01 | 美商英塞特公司 | 作為ｆｇｆｒ抑制劑之雙環雜環 |
| US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| EP4069696A1 (en) | 2019-12-04 | 2022-10-12 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| MX2022006691A (es) | 2019-12-04 | 2022-09-19 | Incyte Corp | Derivados de un inhibidor de receptores del factor de crecimiento de fibroblastos (fgfr). |
| WO2021146424A1 (en) | 2020-01-15 | 2021-07-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| JP2024513575A (ja) | 2021-04-12 | 2024-03-26 | インサイト・コーポレイション | Ｆｇｆｒ阻害剤及びネクチン－４標的化剤を含む併用療法 |
| TW202313611A (zh) | 2021-06-09 | 2023-04-01 | 美商英塞特公司 | 作為ｆｇｆｒ抑制劑之三環雜環 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2949466A (en) * | 1958-03-04 | 1960-08-16 | Parke Davis & Co | Pyrimidine compounds and means of producing the same |
| NL6704601A (pl) | 1966-04-06 | 1967-10-09 | ||
| US4425346A (en) | 1980-08-01 | 1984-01-10 | Smith And Nephew Associated Companies Limited | Pharmaceutical compositions |
| JPS60226882A (ja) * | 1984-04-24 | 1985-11-12 | Nippon Zoki Pharmaceut Co Ltd | 新規ピリミドピリミジン誘導体 |
| WO1998024432A2 (en) | 1996-12-05 | 1998-06-11 | Sugen, Inc. | Use of indolinone compounds as modulators of protein kinases |
| KR200143829Y1 (ko) * | 1996-12-30 | 1999-06-15 | 양재신 | 연료펌프 교환시 연료의 비산 방지구 |
| EA003640B1 (ru) * | 1998-05-26 | 2003-08-28 | Варнер-Ламберт Компани | Бициклические пиримидины и бициклические 3,4-дигидропиримидины как ингибиторы клеточной пролиферации |
| CA2347474C (en) | 1998-10-23 | 2008-08-26 | F. Hoffmann-La Roche Ag | Bicyclic nitrogen heterocycles |
| KR100537241B1 (ko) | 1999-10-21 | 2005-12-19 | 에프. 호프만-라 로슈 아게 | Ｐ38 단백질 키나제의 억제제로서의 알킬아미노 치환된이중고리 질소 헤테로고리 화합물 |
| AU776250B2 (en) | 1999-10-21 | 2004-09-02 | F. Hoffmann-La Roche Ag | Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| AR030053A1 (es) | 2000-03-02 | 2003-08-13 | Smithkline Beecham Corp | 1h-pirimido [4,5-d] pirimidin-2-onas y sales, composiciones farmaceuticas, uso para la fabricacion de un medicamento y procedimiento para producirlas |
| MXPA03001821A (es) | 2000-08-31 | 2003-06-04 | Hoffmann La Roche | 7-oxo-piridopirimidinas como inhibidores de prolieferacion celular. |
| CA2473026C (en) | 2002-01-22 | 2011-05-03 | Warner-Lambert Company Llc | 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| PA8577501A1 (es) | 2002-07-25 | 2004-02-07 | Warner Lambert Co | Inhibidores de quinasas |
| EP1556053A4 (en) | 2002-10-31 | 2006-04-19 | Amgen Inc | ANTI-INFLAMMATORY AGENTS |
-
2003
- 2003-10-20 US US10/689,438 patent/US7129351B2/en not_active Expired - Fee Related
- 2003-10-20 US US10/689,235 patent/US7112676B2/en not_active Expired - Fee Related
- 2003-10-27 MX MXPA05004757A patent/MXPA05004757A/es active IP Right Grant
- 2003-10-27 DE DE60319260T patent/DE60319260T2/de not_active Expired - Fee Related
- 2003-10-27 BR BR0316001-7A patent/BR0316001A/pt not_active IP Right Cessation
- 2003-10-27 AU AU2003276190A patent/AU2003276190A1/en not_active Abandoned
- 2003-10-27 ES ES03758072T patent/ES2300609T3/es not_active Expired - Lifetime
- 2003-10-27 JP JP2004548792A patent/JP2006513999A/ja active Pending
- 2003-10-27 CA CA002502180A patent/CA2502180A1/en not_active Abandoned
- 2003-10-27 EP EP03758072A patent/EP1560829B1/en not_active Expired - Lifetime
- 2003-10-27 JP JP2004548791A patent/JP2006507292A/ja active Pending
- 2003-10-27 AT AT03810410T patent/ATE384725T1/de not_active IP Right Cessation
- 2003-10-27 ES ES03810410T patent/ES2298622T3/es not_active Expired - Lifetime
- 2003-10-27 BR BR0315912-4A patent/BR0315912A/pt not_active IP Right Cessation
- 2003-10-27 AT AT03758072T patent/ATE386744T1/de not_active IP Right Cessation
- 2003-10-27 PL PL376916A patent/PL376916A1/pl not_active Application Discontinuation
- 2003-10-27 KR KR1020077017255A patent/KR100774231B1/ko not_active IP Right Cessation
- 2003-10-27 MX MXPA05004756A patent/MXPA05004756A/es active IP Right Grant
- 2003-10-27 WO PCT/EP2003/011892 patent/WO2004041821A1/en active IP Right Grant
- 2003-10-27 DE DE60318888T patent/DE60318888T2/de not_active Expired - Fee Related
- 2003-10-27 KR KR1020057007906A patent/KR100763300B1/ko not_active IP Right Cessation
- 2003-10-27 KR KR1020057007981A patent/KR100763299B1/ko not_active IP Right Cessation
- 2003-10-27 RU RU2005117341/04A patent/RU2326882C2/ru not_active IP Right Cessation
- 2003-10-27 CN CNA2003801028610A patent/CN1711266A/zh active Pending
- 2003-10-27 WO PCT/EP2003/011896 patent/WO2004041822A1/en active IP Right Grant
- 2003-10-27 PL PL376924A patent/PL376924A1/pl not_active Application Discontinuation
- 2003-10-27 RU RU2005117340/04A patent/RU2331641C2/ru not_active IP Right Cessation
- 2003-10-27 KR KR1020077016286A patent/KR100774230B1/ko not_active IP Right Cessation
- 2003-10-27 EP EP03810410A patent/EP1560832B1/en not_active Expired - Lifetime
- 2003-10-27 CN CNB2003801028485A patent/CN100420688C/zh not_active Expired - Fee Related
- 2003-10-27 CA CA002502182A patent/CA2502182A1/en not_active Abandoned
- 2003-10-31 AR ARP030104000A patent/AR041739A1/es unknown
- 2003-10-31 AR ARP030103999A patent/AR041738A1/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL376916A1 (pl) | Pochodne pirymido [4,5-d] pirymidyny o działaniu przeciwrakowym | |
| EP1599482A4 (en) | PYRAZOLO1,5-A PYRIMIDINE DERIVATIVES | |
| HK1099286A1 (en) | 5,7-diaminopyrazolo [4,3-d] pyrimidines with pde-5 inhibiting activity | |
| IL149026A0 (en) | PYRAZOLO [4, 3-d] PYRIMIDINE DERIVATIVES | |
| HUS1300048I1 (hu) | Új triazolo[4,5-d]pirimidin-származékok | |
| PL373223A1 (pl) | Pochodne 7,8,9,10-tetrahydro-6H-azepino-6,7,8,9-tetrahydropirydo-i 2,3-dihydro-2H-pirolo [2,1-b]-chinazolinonu | |
| TWI365189B (en) | Novel pyrrolo[3,2-d]pyrimidin-4-one derivatives | |
| AP2002002543A0 (en) | Pyrrolo Ä2,3-dÜ pyrimidine compounds | |
| PL1699795T3 (pl) | Podstawione pochodne 8’-piry(mi)dynylo-dihydrospiro-[cykloalkiloamino]-pirymido[1,2-a]pirymidyn-6-onu | |
| ZA200609837B (en) | Octahydro-pyrrolo[3,4-c] derivatives and their use as antiviral compounds | |
| IL151849A0 (en) | Pyrido [2,3-d] pyrimidine and pyrimido [4,5-d] pyrimidine nucleosides | |
| PL377239A1 (pl) | Nowe amino-podstawione pochodne dihydropirymido [4,5-d]-pirymidynonu, ich wytwarzanie i zastosowanie jako środków framaceutycznych | |
| IL170680A0 (en) | 8 - SUBSTITUTED - 6,7,8,9 -TETRAHYDROPYRIMIDO [1,2-a] PYRIMIDIN - 4 - ONE DERIVATIVES | |
| ZA200507192B (en) | Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido [1,2-A] pyrimidin-4-one derivatives | |
| AU4203500A (en) | Pyrazolopyrimidines as crf antagonists | |
| PL370349A1 (pl) | Podstawione pochodne 2-pirydynylo-6,7,8,9-tetrahydro-pirymido[1,2-a]pirymidyn-4-onu i 7-pirydynylo-2,3-dihydroimidazo[1,2-a]pirymidyn-5(1H)onu | |
| DE60103909D1 (de) | 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5 1honderivate | |
| AU2003211993A1 (en) | (1,2,4)TRIAZOLO(1,5-c)PYRIMIDINE DERIVATIVES | |
| GB0131034D0 (en) | Benzocyclodecane derivatives with antitumor activity | |
| IL173347A0 (en) | 7-SUBSTITUTED 3-NITRO-PYRAZOLO[1,5-a] PYRIMIDINES | |
| IL173964A0 (en) | HEXA-AND OCTAHYDRO-PYRIDO[1,2-a]PYRAZINE DERIVATIVES WITH NK1 ANTAGONISTIC ACTIVITY | |
| PL361777A1 (pl) | Podstawione 3,4-dihydropirymido (1,2-a) pirymidyny i 3,4-dihydropirazyno (1,2-a) pirymidyny | |
| TJ431B (en) | 2-Brom-7-methil-5-oxo-5h-1,3,4-thyodyazol-(3,2-a)pyrimidin, has antibacterial activity | |
| ZA200202763B (en) | Pyrazolo [4,3-D] pyrimidine derivatives. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |